Global Expanded Carrier Screening Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Expanded Carrier Screening market size will reach US$ million by 2031.
Expanded reproductive carrier screening is a more comprehensive carrier screen designed for couples, prior to pregnancy. This screen tests the biological mother and the biological father to determine their chance of having a child affected with one or more inherited genetic conditions. Testing covers over 250 different conditions.
United States market for Expanded Carrier Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Expanded Carrier Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Expanded Carrier Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Expanded Carrier Screening players cover Invitae, Fulgent Genetics, LabCorp, VCGS, Myriad Genetics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Expanded Carrier Screening Industry Forecast” looks at past sales and reviews total world Expanded Carrier Screening sales in 2024, providing a comprehensive analysis by region and market sector of projected Expanded Carrier Screening sales for 2025 through 2031. With Expanded Carrier Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Expanded Carrier Screening industry.
This Insight Report provides a comprehensive analysis of the global Expanded Carrier Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Expanded Carrier Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Expanded Carrier Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Expanded Carrier Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Expanded Carrier Screening.
This report presents a comprehensive overview, market shares, and growth opportunities of Expanded Carrier Screening market by product type, application, key players and key regions and countries.
Segmentation by Type:
Customized Panel Testing
Predesigned Panel Testing
Segmentation by Application:
Hospitals
Reference Laboratories
Physician Offices & Clinics
Other End Users
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Invitae
Fulgent Genetics
LabCorp
VCGS
Myriad Genetics
Eurofins Scientific
BGI Genomics
Please note: The report will take approximately 2 business days to prepare and deliver.
Expanded reproductive carrier screening is a more comprehensive carrier screen designed for couples, prior to pregnancy. This screen tests the biological mother and the biological father to determine their chance of having a child affected with one or more inherited genetic conditions. Testing covers over 250 different conditions.
United States market for Expanded Carrier Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Expanded Carrier Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Expanded Carrier Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Expanded Carrier Screening players cover Invitae, Fulgent Genetics, LabCorp, VCGS, Myriad Genetics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Expanded Carrier Screening Industry Forecast” looks at past sales and reviews total world Expanded Carrier Screening sales in 2024, providing a comprehensive analysis by region and market sector of projected Expanded Carrier Screening sales for 2025 through 2031. With Expanded Carrier Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Expanded Carrier Screening industry.
This Insight Report provides a comprehensive analysis of the global Expanded Carrier Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Expanded Carrier Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Expanded Carrier Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Expanded Carrier Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Expanded Carrier Screening.
This report presents a comprehensive overview, market shares, and growth opportunities of Expanded Carrier Screening market by product type, application, key players and key regions and countries.
Segmentation by Type:
Customized Panel Testing
Predesigned Panel Testing
Segmentation by Application:
Hospitals
Reference Laboratories
Physician Offices & Clinics
Other End Users
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Invitae
Fulgent Genetics
LabCorp
VCGS
Myriad Genetics
Eurofins Scientific
BGI Genomics
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
92 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
